Join the LifeTime Community

LifeTime Enabling Technologies

LifeTime has identified an opportunity to combine strategically and co-develop the following technologies
Single-cell multi-omics  and imaging

Single-cell multi-omics and imaging

Artificial intelligence  and machine learning

Artificial intelligence and machine learning

Patient-derived  experimental disease models

Patient-derived experimental disease models

________News________

Latest news and press releases from LifeTime

LifeTime Conference 2.0 – Report

Almost 800 researchers, clinicians, industry partners, policymakers and further stakeholders from 36 countries attended the LifeTime Conference 2.0 on June 16 & 17 which took place as a virtual event. The goal of the pan-European Read more…

COVID-19: Immune system derails

COVID-19: Immune system derails​​ A severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a continuous loop of activation and inhibition. This is Read more…

Make EU health research count!

Ahead of the European Council negotiations on the next Multiannual Financial Framework, academic and industry leaders supporting the LifeTime initiative, have called members of the European Union into action. They ask to preserve the existing Horizon Europe budget and put Read more…

Find us at the office

MDC/BIMSB - Berlin

Dr. Stan Gorski 

Dr. Marie Vidal

Marco Uhrig

Institut Curie - Paris

Dörthe Nickel

Dr. Ines Pinheiro

Contact us at info@lifetime-initiative.eu or use the form on the right.